EPILEPSIES, MYOCLONIC

Clinical trials for EPILEPSIES, MYOCLONIC explained in plain language.

Never miss a new study

Get alerted when new EPILEPSIES, MYOCLONIC trials appear

Sign up with your email to follow new studies for EPILEPSIES, MYOCLONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Drug trial aims to tame severe seizures in rare epilepsy

Disease control Terminated

This study tested whether adding the drug lorcaserin to existing medications could better control convulsive seizures in people with Dravet syndrome, a rare and severe form of childhood epilepsy. It was a Phase 3 trial that enrolled 22 participants, comparing lorcaserin to a plac…

Matched conditions: EPILEPSIES, MYOCLONIC

Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

EPILEPSIES, MYOCLONIC

Get alerted when new EPILEPSIES, MYOCLONIC trials appear

Drug trial aims to tame severe seizures in rare epilepsy